Form D · Pharmaceuticals
Bonovo Orthopedics, Inc.
Scottsdale, AZ · CIK 0001509395
Offering snapshot reported Jan 7, 2011 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $4.5K Reported outside-investor minimum
- First sale
- Dec 7, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2011 | Initial | $10,000,000 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-153258
Source: Form D, filed Jan 7, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Slate | Director, Executive |
| Jonathan Wang | Director |
| Liang Xiaoling | Director |
| Hansen Yuan | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
7702 E. Doubletree Ranch Road, Suite 300
Scottsdale, AZ, 85258
Scottsdale, AZ, 85258